|
Market Closed -
Nasdaq
23:00:00 12/10/2026 +03
|
Pre-market 15:52:22 | |||
| 213.74 USD | -5.00% |
|
207.34 | -2.99% |
| 10-13 | Trading Day: Fog of war | RE |
| 10-13 | TRADING DAY-Fog of war | RE |
| Market Cap | 85.33B 76.39B 71.21B 64.59B 122B 8,157B 123B 856B 335B 4,209B 321B 313B 13,546B | P/E 2026 * |
-25.5x | P/E 2027 * | -44.7x |
|---|---|---|---|---|---|
| Enterprise Value | 81.42B 72.89B 67.95B 61.63B 116B 7,783B 117B 817B 320B 4,016B 306B 299B 12,925B | EV / Sales 2026 * |
38.7x | EV / Sales 2027 * | 34x |
| Free-Float |
92.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MRNA | Delayed | |
CBOE
| MRNA | Real-time | |
Borsa Italiana
| 1MRNA | End-of-day quote | |
Xetra
| 0QF | Delayed | |
Tradegate
| 0QF | Real-time | |
CBOE
| Real-time | ||
CBOE
| 0A45 | Real-time | |
Boerse Muenchen
| 0QF | Real-time | |
Swiss Exchange
| MRNA | Delayed | |
Mexican S.E.
| MRNA * | End-of-day quote | |
Deutsche Boerse AG
| 0QF | Delayed | |
Börse Stuttgart
| 0QF | Delayed | |
Wiener Boerse
| MRNA | End-of-day quote | |
Kazakhstan S.E.
| MRNA_KZ | End-of-day quote | |
London S.E.
| 0A45 | Delayed | |
Lima
| MRNAUS | End-of-day quote | |
Swiss Exchange
| MRNA | Delayed |
Last Transcript: Moderna, Inc.
| 1 day | -2.99% | ||
| 1 week | +5.18% | ||
| Current month | +10.99% | ||
| 1 month | +48.46% | ||
| 3 months | +213.08% | ||
| 6 months | +319.43% | ||
| Current year | +624.79% |
| 1 week | 182.5 | 227.46 | |
| 1 month | 139.02 | 227.46 | |
| Current year | 29.81 | 227.46 | |
| 1 year | 22.28 | 227.46 | |
| 3 years | 22.28 | 227.46 | |
| 5 years | 22.28 | 376.65 | |
| 10 years | 11.54 | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/5/26 A | Other | Chief Operating Officer | 125,000 | 0.0313% | ||
| 10/5/26 A | Exercice | Chief Financial Officer | 3,612 | 0.0009% | ||
| 9/15/26 A | Exercice | Chairperson | 193,185 | 0.0484% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.00% | +5.18% | +696.65% | +112.09% | 85.33B | ||
| +0.28% | +3.46% | +41.89% | +93.71% | 1,054B | ||
| +0.88% | +4.27% | +38.28% | +68.70% | 636B | ||
| +1.68% | +5.78% | +21.96% | +89.56% | 497B | ||
| -0.10% | +4.24% | +69.15% | +40.41% | 359B | ||
| +1.04% | +3.97% | +25.37% | +42.60% | 345B | ||
| +0.83% | +3.23% | +15.75% | +38.21% | 273B | ||
| +1.19% | +1.74% | -4.39% | +10.86% | 246B | ||
| +0.65% | +3.62% | +43.93% | +46.50% | 226B | ||
| -0.49% | +4.01% | +28.38% | +95.97% | 187B | ||
| Average | +0.16% | +3.35% | +97.70% | +63.86% | 390.75B | |
| Weighted average by Cap. | +0.24% | +3.24% | +48.84% | +68.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.1B 1.88B 1.75B 1.59B 3B 201B 3.02B 21.07B 8.25B 104B 7.89B 7.72B 334B | 2.44B 2.18B 2.04B 1.85B 3.48B 233B 3.5B 24.46B 9.57B 120B 9.16B 8.96B 387B |
| Net income | -3.36B -3.01B -2.8B -2.54B -4.79B -321B -4.82B -33.68B -13.18B -166B -12.62B -12.34B -533B | -1.92B -1.71B -1.6B -1.45B -2.73B -183B -2.75B -19.21B -7.52B -94.47B -7.19B -7.03B -304B |
| Net Debt | -3.91B -3.5B -3.27B -2.96B -5.59B -374B -5.62B -39.24B -15.36B -193B -14.7B -14.37B -621B | -2.44B -2.19B -2.04B -1.85B -3.49B -234B -3.51B -24.51B -9.6B -121B -9.18B -8.98B -388B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/10/26 | $213.74 | -5.00% | 12,873,864 |
| 09/10/26 | $225.00 | +14.21% | 28,947,262 |
| 08/10/26 | $197.00 | +0.26% | 37,399,978 |
| 07/10/26 | $196.48 | +4.81% | 14,640,181 |
| 06/10/26 | $187.46 | -7.75% | 18,794,807 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Select your edition
All financial news and data tailored to specific country editions



















